Hjem › Kronisk myelomonocytisk leukæmi › Florida
Kronisk myelomonocytisk leukæmi kliniske forsøg i Florida
8 studier for Kronisk myelomonocytisk leukæmi søger deltagere på steder i Florida.
Byer i Florida
Officiel studietekst (engelsk)
A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.
- University of Miami, Miami
RekruttererFase 2Frivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT06566742Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia
- Moffitt Cancer Center, Tampa
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT07033598Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
- Allergy, Asthma, & Immunology Associates of Tampa Bay, Tampa
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 12. aug. 2026 · NCT07143669A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 30. apr. 2026 · NCT04256317A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- University of Miami, Miami
RekruttererFase 2
Alder 18 til 66 · Alle køn · Opdateret 17. mar. 2026 · NCT06859424A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
- Moffitt Cancer Center, Tampa
RekruttererFase 1
Alder 12 og opefter · Alle køn · Opdateret 16. mar. 2026 · NCT06994676A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
- Moffitt, Tampa
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 9. feb. 2026 · NCT06950034Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- University of Miami - Miller School of Medicine, Miami
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 26. aug. 2025 · NCT03850574Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.